Stock listing
NASDAQ:MNKD MannKind Corporation Stock
Home listing (NASDAQ) of MannKind Corporation
Follow MannKind Corporation into a list and get an email when it puts out news.
Share price · NASDAQ:MNKD
$3.50 USD 0.00 (0.0%)
Close on Oct 30, 2026
- Day range
- $3.45 – $3.57 USDOct 30, 2026
- Volume
- 2.01M sharesOct 30, 2026
- Market cap
- $1.13B USDAt the close on Oct 30, 2026 · price × 321.5M shares outstanding
- 52-week range
- $2.23 – $6.51 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $15.55M USDMedian day 3.21M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MNKD · Home | $3.50 USD | 0.00 (0.0%) | 2,009,438 | $3.50 | $3.57 | $3.45 | $3.50 | Close on Oct 30, 2026 |
| Frankfurt:NNFN | €3.078 EUR | +0.236 (+8.3%) | — | €3.078 | €3.078 | €3.078 | €2.842 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:MNKD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.50 | 0.00 | 0.0% | $3.50 | $3.57 | $3.45 | 2,009,438 | |
| $3.50 | +0.07 | +2.0% | $3.49 | $3.57 | $3.48 | 2,271,081 | |
| $3.43 | +0.14 | +4.3% | $3.26 | $3.465 | $3.235 | 3,076,665 | |
| $3.29 | +0.06 | +1.9% | $3.23 | $3.30 | $3.17 | 2,501,299 | |
| $3.23 | +0.04 | +1.3% | $3.22 | $3.275 | $3.15 | 1,976,493 | |
| $3.19 | -0.01 | -0.3% | $3.18 | $3.21 | $3.09 | 3,088,400 | |
| $3.20 | +0.15 | +4.9% | $3.03 | $3.21 | $3.01 | 3,254,700 | |
| $3.05 | -0.05 | -1.6% | $3.10 | $3.13 | $3.04 | 2,798,700 | |
| $3.10 | +0.01 | +0.3% | $3.11 | $3.18 | $3.08 | 2,170,400 | |
| $3.09 | +0.05 | +1.6% | $3.18 | $3.22 | $3.07 | 2,463,000 | |
| $3.04 | -0.15 | -4.7% | $3.20 | $3.24 | $3.02 | 2,605,500 | |
| $3.19 | +0.17 | +5.6% | $3.02 | $3.20 | $3.00 | 3,756,500 | |
| $3.02 | -0.03 | -1.0% | $3.00 | $3.13 | $2.90 | 7,933,900 | |
| $3.05 | -0.08 | -2.6% | $3.13 | $3.14 | $3.02 | 4,394,000 | |
| $3.13 | -0.16 | -4.9% | $3.24 | $3.27 | $3.08 | 3,957,000 | |
| $3.29 | -0.13 | -3.8% | $3.40 | $3.41 | $3.23 | 4,549,500 | |
| $3.42 | -0.03 | -0.9% | $3.42 | $3.53 | $3.33 | 4,539,700 | |
| $3.45 | -0.26 | -7.0% | $3.67 | $3.68 | $3.39 | 6,005,300 | |
| $3.71 | -0.11 | -2.9% | $3.86 | $3.86 | $3.69 | 3,069,900 | |
| $3.82 | +0.02 | +0.5% | $3.82 | $3.85 | $3.70 | 2,876,200 | |
| $3.80 | -0.15 | -3.8% | $4.01 | $4.01 | $3.71 | 4,610,100 | |
| $3.95 | +0.05 | +1.3% | $3.84 | $4.23 | $3.83 | 10,190,800 | |
| $3.90 | +0.56 | +16.8% | $3.37 | $4.03 | $3.30 | 15,020,200 | |
| $3.34 | -0.01 | -0.3% | $3.35 | $3.38 | $3.28 | 2,378,100 | |
| $3.35 | +0.01 | +0.3% | $3.34 | $3.38 | $3.28 | 2,077,500 | |
| $3.34 | +0.05 | +1.5% | $3.32 | $3.39 | $3.17 | 8,852,600 | |
| $3.29 | -0.05 | -1.5% | $3.33 | $3.33 | $3.23 | 2,964,300 | |
| $3.34 | -0.15 | -4.3% | $3.48 | $3.48 | $3.34 | 2,874,900 | |
| $3.49 | -0.01 | -0.3% | $3.53 | $3.55 | $3.26 | 16,298,900 | |
| $3.50 | -0.04 | -1.1% | $3.55 | $3.62 | $3.47 | 4,524,600 | |
| $3.54 | -0.04 | -1.1% | $3.59 | $3.62 | $3.50 | 5,512,800 | |
| $3.58 | +0.03 | +0.8% | $3.61 | $3.68 | $3.53 | 2,733,100 | |
| $3.55 | -0.01 | -0.3% | $3.57 | $3.61 | $3.52 | 2,225,500 | |
| $3.56 | -0.19 | -5.1% | $3.74 | $3.75 | $3.54 | 3,697,300 | |
| $3.75 | 0.00 | 0.0% | $3.76 | $3.84 | $3.73 | 3,129,200 | |
| $3.75 | -0.04 | -1.1% | $3.83 | $3.85 | $3.73 | 2,469,800 | |
| $3.79 | -0.15 | -3.8% | $3.90 | $3.90 | $3.76 | 3,209,500 | |
| $3.94 | -0.22 | -5.3% | $4.16 | $4.36 | $3.92 | 5,190,100 | |
| $4.16 | +0.10 | +2.5% | $4.00 | $4.32 | $4.00 | 4,930,900 | |
| $4.06 | +0.10 | +2.5% | $3.92 | $4.10 | $3.92 | 2,806,300 | |
| $3.96 | -0.08 | -2.0% | $4.05 | $4.07 | $3.96 | 2,331,100 | |
| $4.04 | +0.06 | +1.5% | $3.97 | $4.09 | $3.97 | 2,590,500 | |
| $3.98 | -0.03 | -0.7% | $3.97 | $4.03 | $3.95 | 2,234,800 | |
| $4.01 | +0.06 | +1.5% | $3.94 | $4.02 | $3.90 | 2,805,200 | |
| $3.95 | -0.11 | -2.7% | $4.06 | $4.08 | $3.93 | 1,984,100 | |
| $4.06 | -0.03 | -0.7% | $4.05 | $4.12 | $4.04 | 2,067,800 | |
| $4.09 | -0.07 | -1.7% | $4.16 | $4.19 | $4.05 | 1,766,300 | |
| $4.16 | +0.09 | +2.2% | $4.10 | $4.235 | $4.10 | 3,193,655 | |
| $4.07 | -0.08 | -1.9% | $4.13 | $4.14 | $4.06 | 2,812,485 | |
| $4.15 | -0.11 | -2.6% | $4.28 | $4.36 | $4.11 | 3,204,500 | |
| $4.26 | -0.14 | -3.2% | $4.35 | $4.36 | $4.14 | 3,416,000 | |
| $4.40 | +0.33 | +8.1% | $4.10 | $4.40 | $4.10 | 5,435,500 | |
| $4.07 | +0.17 | +4.4% | $3.87 | $4.10 | $3.87 | 4,600,200 | |
| $3.90 | +0.05 | +1.3% | $3.85 | $3.94 | $3.80 | 3,322,300 | |
| $3.85 | +0.12 | +3.2% | $3.74 | $3.85 | $3.69 | 2,855,300 | |
| $3.73 | -0.12 | -3.1% | $3.88 | $3.90 | $3.63 | 5,239,900 | |
| $3.85 | +0.01 | +0.3% | $3.86 | $3.92 | $3.84 | 3,056,000 | |
| $3.84 | -0.09 | -2.3% | $3.91 | $3.98 | $3.82 | 4,497,500 | |
| $3.93 | -0.18 | -4.4% | $4.07 | $4.08 | $3.88 | 4,157,400 | |
| $4.11 | +0.22 | +5.7% | $3.91 | $4.15 | $3.85 | 5,048,100 | |
| $3.89 | -0.21 | -5.1% | $3.82 | $3.93 | $3.69 | 9,306,200 | |
| $4.10 | +0.14 | +3.5% | $3.93 | $4.14 | $3.90 | 6,833,500 | |
| $3.96 | +0.16 | +4.2% | $3.82 | $4.00 | $3.78 | 5,118,100 | |
| $3.80 | -0.11 | -2.8% | $3.96 | $3.96 | $3.78 | 5,276,500 | |
| $3.91 | -0.20 | -4.9% | $4.09 | $4.14 | $3.85 | 5,404,100 | |
| $4.11 | +0.26 | +6.8% | $3.90 | $4.12 | $3.88 | 4,140,700 |
- Ticker
- NASDAQ:MNKD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026
Latest earnings call · Aug 5, 2026
Mannkind (NASDAQ:MNKD) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 5, 2026
Q2 2026 Earnings Presentation
Earnings · 36 slides
Calls
Upcoming
Mannkind (NASDAQ:MNKD) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Register
Replays
Mannkind (NASDAQ:MNKD) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptMannkind (NASDAQ:MNKD) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch TranscriptMannkind (NASDAQ:MNKD) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 9:00 AM ET
Watch Transcript
Latest news
MannKind to Report Third Quarter Financial Results and Host Conference Call on November 5, 2026
Oct 29, 2026
Closed $3.50 (0.0%) on Oct 30, 2026
MannKind to Participate in the Chardan Healthcare Conference
Oct 14, 2026
Closed $3.19 (+5.6%) on Oct 15, 2026
MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)
Oct 9, 2026
Closed $3.29 (-3.8%) on Oct 9, 2026
MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management
Sep 9, 2026
Closed $3.94 (-5.3%) on Sep 9, 2026
MannKind Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 5, 2026
Closed $3.89 (-5.1%) on Aug 6, 2026
MannKind Reports Positive Phase 1b INFLO-1 Results, Demonstrating Safety and Tolerability of Nintedanib DPI and Clinical Validation of Its DPI Technology in IPF
Jul 29, 2026
Closed $3.85 (-1.5%) on Jul 29, 2026
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
Jul 28, 2026
Closed $3.85 (-1.5%) on Jul 29, 2026
MannKind Announces FDA Approval of Furoscix ReadyFlow, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
Jul 27, 2026
Closed $3.95 (-4.4%) on Jul 27, 2026
MannKind Announces $50 Million Private Placement
Jul 24, 2026
Closed $4.13 (+6.2%) on Jul 24, 2026
Financings
Private placement of unstated
Aug 5, 2026
Closed: US$50M raised · US$3.89 a share
Buyers: Frazier Life Sciences
Use of proceeds: To fund the $45 million CVR payment triggered by the FDA approval of Furoscix ReadyFlow
Decks
Q2 2026 Earnings Presentation
Earnings · 36 slides · Aug 5, 2026
Investor Presentation (August 2026)
Investor deck · 34 slides · August 2026
Technical Presentation (July 2026)
Technical · 34 slides · Jul 29, 2026
Corporate Update (July 2026)
Corporate update · 23 slides · Jul 24, 2026
MannKind Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 207 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 5, 2026
- Decks
- 7 decks · latest Aug 5, 2026
Where MannKind Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MNKD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MNKD | BOATS | United States | USD |
| gettex:NNFN | gettex | Germany | EUR |
| LS Exchange:A2DMZL | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2DMZL | Lang & Schwarz | Germany | EUR |
| Tradegate:NNFN | Tradegate | Germany | EUR |
| Munich:NNFN | Munich | Germany | EUR |
| BX Swiss:NNFN | BX Swiss | Switzerland | CHF |
| Dusseldorf:NNFN | Dusseldorf | Germany | EUR |
| Frankfurt:NNFN | Frankfurt | Germany | EUR |
| Stuttgart:NNFN | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about MannKind Corporation.